Summarizing our findings, DMF, which exerts anti-inflammatory as well as Nrf2-activating properties, might positively influence the course of relapsing-remitting MS by inhibiting microglial and astroglial activation and subsequent release of pro-inflammatory neurotoxic mediators. Here, NFE2L2 is linked to relapsing-remitting multiple sclerosis.